Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:23 PM
Ignite Modification Date:
2025-12-24 @ 2:23 PM
NCT ID:
NCT07198659
Eligibility Criteria:
Inclusion Criteria:
* 18-70 years
* Obtain an informed consent form voluntarily signed by the patient themselves
* patients with Unresectable Pancreatic Cancer confirmed by Histopathology
* Patients who either: 1) have received standard first-line treatments, proven ineffective or causing intolerable adverse effects; or 2) have not received the standard first-line treatments and voluntarily opt for Autologous Drug-Loaded Neutrophils (NeuMed)-based therapy
* EOCG score ≤ 2 and expected survival time ≥ 3 months
* Liver, kidney and bone marrow functions are basically normal
Exclusion Criteria:
* Patients who required anti coagulant therapy
* Patients with active infectious diseases or a history of bone marrow or organ transplantation
* Patients with autoimmune diseases or autoinflammatory diseases
* Patients with a history of severe cardiovascular or cerebrovascular diseases or interstitial lung disease or non-infectious pneumonia
* Patients who have received live vaccines within 30 days prior to enrollment
* Patients with no response to bone marrow mobilization
* Other patients deemed unsuitable for enrollment by the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT07198659
Study Brief:
Protocol Section:
NCT07198659